rMVA-CD40L

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamerMVA-CD40L
Drug Alias NamerMVA-CD40L
ClassificationVaccines
Mechanisms of ActionImmunostimulantsNatural killer cells stimulantsT lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBavarian Nordic A/S
China Registration ClassN/A

Develop Information

Active CompaniesBavarian Nordic A/S
Inactive CompaniesN/A
Active IndicationsSolid tumoursColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A